Solicitor general Tushar Mehta infomed a bench headed by Justice DY Chandrachud that the committee headed by ex-finance secretary Ajay Bhushan Pandey, which was tasked to revisit the criteria for candidate’s inclusion in EWS category, has already submitted its recommendations and that the Centre has filed the report before the court.
from Times of India https://ift.tt/3eMZ1jB
via
Monday, January 3, 2022
Covid antiviral pill launched at 1,399 for full 5-day course
Over a dozen companies, including Hetero, Sun Pharma, Natco and Dr Reddy’s are in the process of rolling out the oral therapy developed by Merck and and its partner, Ridgeback Biotherapeutics, at prices ranging between Rs 1,500 and Rs 2,500 for the complete treatment, sources told TOI.
from Times of India https://ift.tt/3qHDw9y
via
from Times of India https://ift.tt/3qHDw9y
via
Sunday, January 2, 2022
Ramp up vaccine coverage: Centre to poll-bound states
Uttarakhand forms SIT to probe ‘hate speech’
DIG Garhwal Karan Singh Nagnyal said that the SIT is headed by Dehradun SP (rural) Kamlesh Upadhyay and has one circle officer, one inspector and two sub-inspectors as its members. “The decision to form the SIT was taken since the issue is sensitive", he said.
from Times of India https://ift.tt/3sOJlEy
via
from Times of India https://ift.tt/3sOJlEy
via
India’s Omicron count crosses 1,700-mark
‘Foreign test kits can’t spot Omicron’s elusive sibling’
The elusive sibling (sub-lineage) of the Omicron variant, BA.2, cannot be picked up by the imported RT-PCR kit having an S-gene drop, researchers involved in tracking the virus in India said on Sunday. The variant has three sub-lineages BA.1, BA.2, and BA.3.
from Times of India https://ift.tt/3pN6sOb
via
from Times of India https://ift.tt/3pN6sOb
via
Subscribe to:
Posts (Atom)